|
|
||||||||
Technical Innovation |
1
Department of Radiology, University of Washington, Harborview Medical Center,
Box 359728, 325 Ninth Ave., Seattle, WA 98104.
2
Department of Obstetrics and Gynecology, University of Washington, Harborview
Medical Center, Seattle, WA 98104.
Received August 30, 1999;
accepted after revision October 13, 1999.
Address correspondence to T. J. Dubinsky.
Introduction
|
|
|---|
|
|
|---|
All women underwent endovaginal sonography with a Prima (Siemens, Redmond, WA), an HDI 3000 (Applied Technologies Laboratories, Bothell, WA), or a Logiq 700 (General Electric Medical Systems, Milwaukee, WI) scanner and 5-MHz or multifrequency endovaginal transducers. The double-layer endometrial thickness was measured in the sagittal plane. Perimenopausal and postmenopausal women with a thickened endometrium, defined as greater than 5 mm, and premenopausal women with an endometrium thicker than 16 mm underwent hysterosonography using one of the following catheters: a 9-French Selecta-Cath System cervical-access catheter (Ackrad Laboratories, Cranford, NJ), a 12-French balloon cervical cannula (Cook OB/GYN, Spencer, IN), or a 9- or 12-French balloon cervical-access prototype designed specifically for hysterosonographically guided endometrial biopsy procedures (Cook OB/GYN). The first two cervical-access catheters were tested with and without the inner coaxial-guidance catheters (packaged for cannulation of the fallopian tubes).
We placed these catheters in the cervix using the standard procedure described for hysterosonography [5]. Although many women had endometrial thickening on endovaginal sonography, the only women we included in this series were those with focal or diffuse endometrial thickening on hysterosonography, and it is these women who subsequently underwent guided biopsy. We did not attempt to biopsy focal mass lesions such as polyps or fibroids, and we did not include women with these findings in this series. We gave no antibiotics prophylactically.
We biopsied the endometrium by placing a 5-French flexible biopsy forceps (Cook OB/GYN) coaxially through the cervix. Each combination of catheter and biopsy device was evaluated for adequacy of control of uterine distention, visibility under sonographic guidance, steerability, and success in obtaining an adequate specimen.
All women undergoing a biopsy received a paracervical block using lidocaine. After the hysterosonography and biopsy procedure, the gynecologist performed aspiration curettage using a 7-mm sterile vacuum curette (Synemed, Berkeley, CA) to completely evacuate the uterus. Endometrial hysterosonographically guided biopsy specimens were placed in formalin containers separate from those obtained with the vacuum curette so the specimens could be compared. The curettage specimens served as the control against which the flexible-forceps specimens were compared. We administered conscious IV sedation, including 1 mg of midazolam and 50 µg of fentanyl citrate, to all the women.
|
|
|---|
|
|
|---|
The flexible forceps were readily visible (Fig. 1A). With the uterus empty of saline, the forceps were still quite visible (Fig. 1B). Visualization was important for guiding the device to the correct site for the biopsy and for determining when the device had been advanced to the end of the catheter to be free within the endometrial canal. No complications occurred during the biopsy procedures.
|
|
The biopsy device we tested, flexible forceps, cannot be steered independently. It requires an external catheter to guide it to the area of the endometrial abnormality. The catheters we tested initially were all straight, which restricted their ability to direct the biopsy device. Depending on uterine position, only the fundus could be biopsied. This was not important when the endometrium was diffusely thickened as in the patients with hyperplasia. In the one patient with endometrial carcinoma, the forceps could not be steered to the mass.
Our pathologists found that the biopsy specimens obtained with the flexible forceps led to the correct diagnosis as often as those obtained with endometrial biopsies, although we did not directly compare such specimens in this study. All the pathologists agreed that a typical specimen (Fig. 1C) was more than adequate to exclude carcinoma. A solitary specimen obtained with the forceps yielded adequate material for interpretation in each case, yet we have not proven how many samples should be obtained to adequately evaluate the endometrium.
|
Our study was designed so that each woman could undergo a hysterosonographically guided biopsy followed by a more invasive vacuum curettage. It has not been established whether such vacuum curetting is necessary in most cases, and questions remain regarding the proper amount of sedation and analgesia for this procedure. For this study, vacuum curettage provided comparison for our hysterosonographic biopsy samples. We have not proven that hysterosonographically guided endometrial biopsies can be performed routinely as an outpatient procedure without the use of sedation and local anesthesia. With smaller catheters this may be possible.
It would be useful if a woman shown to have both diffuse and particularly focal endometrial thickening on hysterosonography (which we have previously shown to be associated with an increased risk for malignancy [8]) could undergo a biopsy using the same catheter. This would save the patient a second procedure and ensure that the appropriate site had been sampled. Although polypectomies could probably be performed in this manner, the amount of pain associated with this procedure without general anesthesia may be unacceptable, and further investigation into the clinical feasibility of outpatient polypectomy is needed.
We have shown that it is technically feasible to perform hysterosonographically guided endometrial biopsies, but further redesign of existing catheters would be necessary to make this clinically applicable, particularly in outpatients.
Acknowledgments
We thank Brent Lopez for manuscript preparation and David Green and Colleen
Elerick for their invaluable help with this project.
|
|
|---|
This article has been cited by other articles:
![]() |
D. L. Berridge and T. C. Winter Saline Infusion Sonohysterography: Technique, Indications, and Imaging Findings J. Ultrasound Med., January 1, 2004; 23(1): 97 - 112. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |